These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 4404559)

  • 1. Significance of cell interactions in production of graft versus host splenomegaly.
    Barchilon J; Liebhaber SA; Gershon RK
    Yale J Biol Med; 1972 Oct; 45(5):519-29. PubMed ID: 4404559
    [No Abstract]   [Full Text] [Related]  

  • 2. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 3. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT; Wagner H
    J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation and suppression of graft-versus-host reaction.
    Nouza K; Pichlílová
    Allerg Immunol (Leipz); 1973; 19(2-4):279-89. PubMed ID: 4156162
    [No Abstract]   [Full Text] [Related]  

  • 5. T cells and the immune response.
    Cantor H
    Prog Biophys Mol Biol; 1972; 25():73-82. PubMed ID: 4145303
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of marrow allograft rejection with radioactive strontium: evidence for marrow-dependent effector cells.
    Bennett M
    J Immunol; 1973 Feb; 110(2):510-6. PubMed ID: 4405320
    [No Abstract]   [Full Text] [Related]  

  • 7. Status of T- and B-cell cooperation in radiation chimeras: evidence for a suppressor effect.
    Gengozian N; Urso P
    Transplant Proc; 1976 Dec; 8(4):631-5. PubMed ID: 793116
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
    Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
    Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
    [No Abstract]   [Full Text] [Related]  

  • 9. The double barrier in bone marrow transplantation.
    van Bekkum DW
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune responses of rats deficient in thymus-derived lymphocytes to strong transplantation antigens (Ag-B). Graft-versus-host activity, allograft rejection, and the factor of immunization.
    Rolstad B; Ford WL
    Transplantation; 1974 Apr; 17(4):405-15. PubMed ID: 4150884
    [No Abstract]   [Full Text] [Related]  

  • 11. Soluble H-2 antigens: effect on graft-versus-host reaction and factors influencing its effect on host-versus-skin-graft reaction.
    Halle-Pannenko O; Martyre MC; Mathé G
    Transplant Proc; 1972 Dec; 4(4):517-21. PubMed ID: 4405145
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppression and malignant lymphomas in graft-versus-host reactions.
    Solnik C; Gleichmann H; Kavanah M; Schwartz RS
    Cancer Res; 1973 Sep; 33(9):2068-77. PubMed ID: 4146854
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of macrophages, thymus- and bone marrow-derived cells in the graft-versus-host reaction.
    Argyris B
    Transplantation; 1974 Apr; 17(4):387-91. PubMed ID: 4150882
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro sensitization to transplantation antigens. V. Suppression of T-cell and of B-cell function in vitro.
    Dyminski JW; Argyris BF
    Cell Immunol; 1972 Dec; 5(4):561-9. PubMed ID: 4565650
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow transplantation in inbred strains of mice. I. The failure of development of normal T cell function following allogeneic transplantation.
    Trier L; Rubin B
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):724-32. PubMed ID: 4139875
    [No Abstract]   [Full Text] [Related]  

  • 16. Graft-versus-host response, measured by splenomegaly assay, by populations of allosensitized mouse lymphocytes.
    Lilliehöök B; Blomgren H
    Cell Immunol; 1976 May; 23(2):203-10. PubMed ID: 6152
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The graft-versus-host reaction.
    Seemayer TA; Gartner JG; Lapp WS
    Hum Pathol; 1983 Jan; 14(1):3-5. PubMed ID: 6219931
    [No Abstract]   [Full Text] [Related]  

  • 19. Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation.
    Pachnio A; Dietrich S; Klapper W; Humpe A; Schwake M; Sedlacek R; Gramatzki M; Beck C
    Bone Marrow Transplant; 2006 Jul; 38(2):157-67. PubMed ID: 16820783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.